Literature DB >> 1891795

Serial immunoreactive erythropoietin levels in autologous blood donors.

A Lorentz1, A Jendrissek, K U Eckardt, M Schipplick, P M Osswald, A Kurtz.   

Abstract

The variations in plasma erythropoietin (EPO) concentration during preoperative deposit of autologous blood were studied in 12 patients (8 men, 4 women). Four donations were scheduled at weekly intervals. A predonation hemoglobin concentration of 11 g per dL (110 g/L) was required. Hemoglobin concentration decreased from 14.3 +/- 1.1 g per dL (143 +/- 11 g/L) (mean +/- SD) before the first donation to 11.7 +/- 0.7 g per dL (117 +/- 7 g/L) on Day 22 (p less than or equal to 0.0001). Reticulocyte counts increased from a median of 31,800 (range, 4900-95,000) per microL (median, 32 x 10(9)/L [range, 5-95 x 10(9)/L]) to 93,800 (16,800-194,900) per microL (median, 94 x 10(9)/L [range, 17-195 x 10(9)/L]) on Day 28 (p less than or equal to 0.01). Plasma EPO concentration was 17.8 +/- 5.1 mU per mL prior to the first donation and displayed a small and transient peak after each donation. A sustained elevation followed each peak. Although plasma EPO concentration differed significantly from the baseline value after the first donation, only the peak concentrations after the second (35.5 +/- 15.5 mU/mL), third (38.0 +/- 14.5 mU/mL), and fourth (36.1 +/- 11.0 mU/mL) donations exceeded the normal range. The moderate, biphasic increase in plasma EPO concentration and the moderate increase in erythropoiesis suggest two strategies in autologous blood donation that should be investigated with respect to efficiency and safety: 1) more aggressive donation schemes, which reduce donation intervals and/or the minimum hemoglobin concentration and 2) the administration of recombinant human EPO.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1891795     DOI: 10.1046/j.1537-2995.1991.31791368345.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  8 in total

Review 1.  Pre-operative autologous blood donation: clinical parameters and efficacy.

Authors:  Günter Singbartl
Journal:  Blood Transfus       Date:  2011-01       Impact factor: 3.443

2.  Erythropoietin levels in patients depositing autologous blood in short intervals.

Authors:  A Lorentz; K U Eckardt; P M Osswald; J R Duchow
Journal:  Ann Hematol       Date:  1992-06       Impact factor: 3.673

3.  Perioperative plasma erythropoietin levels in hip arthroplasty.

Authors:  A Lorentz; K U Eckardt; P M Osswald; C Kruse
Journal:  Ann Hematol       Date:  1994-03       Impact factor: 3.673

Review 4.  Pharmacological approaches to reduce perioperative transfusion requirements in the aged.

Authors:  T Tasaki; H Ohto; R Motoki
Journal:  Drugs Aging       Date:  1995-02       Impact factor: 3.923

Review 5.  Iron and anemia in human biology: a review of mechanisms.

Authors:  Garry J Handelman; Nathan W Levin
Journal:  Heart Fail Rev       Date:  2008-03-25       Impact factor: 4.214

Review 6.  Epoetin alfa. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in nonrenal applications.

Authors:  A Markham; H M Bryson
Journal:  Drugs       Date:  1995-02       Impact factor: 9.546

7.  Effects of serial phlebotomy on vascular endothelial function: Results of a prospective double-blind randomized study.

Authors:  Qurat-Ul-Ain Jelani; Bhisham Harchandani; Ritchard G Cable; Yu Guo; Hua Zhong; Timothy Hilbert; Jonathan D Newman; Stuart D Katz
Journal:  Cardiovasc Ther       Date:  2018-11-13       Impact factor: 3.023

Review 8.  Relation between Exercise Performance and Blood Storage Condition and Storage Time in Autologous Blood Doping.

Authors:  Benedikt Seeger; Marijke Grau
Journal:  Biology (Basel)       Date:  2020-12-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.